Development and Internal Validation of the RMC-COMPASS Clinical Prognostic Model for SMARCB1-deficient Renal Medullary Carcinoma
- DOI
- 10.1016/j.euo.2026.10.006
- Published
- 2026-11
- Container
- European Urology Oncology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.euo.2026.10.006,
title = {Development and Internal Validation of the RMC-COMPASS Clinical Prognostic Model for SMARCB1-deficient Renal Medullary Carcinoma},
author = {Stepan M. Esagian and Peng Yang and Alexander D. Sherry and Rahul A. Sheth and Jose A. Karam and Najat C. Daw and Chad Tang and Nizar M. Tannir and Pavlos Msaouel},
year = {2026},
journal = {European Urology Oncology},
doi = {10.1016/j.euo.2026.10.006},
url = {https://doi.org/10.1016/j.euo.2026.10.006}
}RIS
TY - JOUR TI - Development and Internal Validation of the RMC-COMPASS Clinical Prognostic Model for SMARCB1-deficient Renal Medullary Carcinoma AU - Stepan M. Esagian AU - Peng Yang AU - Alexander D. Sherry AU - Rahul A. Sheth AU - Jose A. Karam AU - Najat C. Daw AU - Chad Tang AU - Nizar M. Tannir AU - Pavlos Msaouel PY - 2026 JO - European Urology Oncology DO - 10.1016/j.euo.2026.10.006 UR - https://doi.org/10.1016/j.euo.2026.10.006 ER -
APA
Esagian, S. M., Yang, P., Sherry, A. D., Sheth, R. A., Karam, J. A., Daw, N. C., Tang, C., Tannir, N. M., & Msaouel, P. (2026). Development and Internal Validation of the RMC-COMPASS Clinical Prognostic Model for SMARCB1-deficient Renal Medullary Carcinoma. European Urology Oncology. https://doi.org/10.1016/j.euo.2026.10.006
Source records
- crossref · retrieved 2026-11-08T10:29:24.543Z